ProForma 2.0
validated simple linear
AIGSILGALAKGLPTLISWIKNR
Record tools
Copy identifiers or export this single peptide record for a local research note.
Prepromelittin-related peptide, MRP, AR-23
75
Quality PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness.
6
Source DBs
69
Activities
7
Source refs
6
Literature
0
Patents
Integrated record
Length
Molecular weight
Formula
Structure type
Synthesis
Chirality
Family
Gene
Residue composition
Physicochemical profile
Membrane affinity proxy
Solubility proxy
Net charge proxy +3
Binding interaction proxy
Versioned scientific descriptors
Legacy compatibility fields are materialized from the versioned PepDiana computed release; no separate source-reported property is available.
Molecular weight
2392.8802 Da
Molecular formula
C111H190N30O28
Theoretical pI
11.1664
Net charge at pH 7
2.7939
GRAVY
0.7304
Instability index
15.2391
Aromaticity
0.0435
Topological polar surface area
928.24 Ų
cLogP
-6.6211
Hydrogen-bond donors
33
Hydrogen-bond acceptors
31
Rotatable bonds
79
Method: PepDiana sequence/structure descriptor pipeline
Tool: Biopython+RDKit · Biopython 1.85; RDKit 2024.09.6
Calculated: 2026-06-20T11:01:38.358971+00:00
Assumptions: ph=7; termini=free N-terminus and free C-terminus for simple linear peptides; stereochemistry=standard L-amino acids; smiles_length_limit=200
ProForma 2.0
validated simple linear
AIGSILGALAKGLPTLISWIKNR
HELM 2.0
validated simple linear
PEPTIDE1{A.I.G.S.I.L.G.A.L.A.K.G.L.P.T.L.I.S.W.I.K.N.R}$$$$V2.0
Canonical SMILES
validated
CCC(C)C(NC(=O)C(C)N)C(=O)NCC(=O)NC(CO)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(CO)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(CC(N)=O)C(=O)NC(CCCNC(=N)N)C(=O)O)C(C)CC)C(C)CC)C(C)O)C(C)CC
Isomeric SMILES
validated
CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC
Follow-up research
Links open third-party resources with the current PepDiana sequence, record name, or chemistry notation as the initial query.
Research workflow
@misc{PEPDIA-INT-014813,
title = {Prepromelittin-related peptide, MRP, AR-23},
author = {{PepDiana Consortium}},
year = {2026},
howpublished = {PepDiana Multifunctional Peptide Database},
url = {http://127.0.0.1:3004/peptides/PEPDIA-INT-014813},
note = {Accessed from local PepDiana development build}
}Prepromelittin-related peptide, MRP, AR-23. (2026). PepDiana record PEPDIA-INT-014813. PepDiana Multifunctional Peptide Database. http://127.0.0.1:3004/peptides/PEPDIA-INT-014813
Integrated source-database annotations
| Stable record | Activity | Subtype | Value | Target | Assay method | Source |
|---|---|---|---|---|---|---|
| CTPDB_P014813_ACT_apd_0000 | Antimicrobial | Anti-Gram+ | Not available in the current structured import | Unknown | Not reported by source | AP00694apd / linked |
| CTPDB_P014813_ACT_apd_0001 | Antiviral | - | Not available in the current structured import | Unknown | Not reported by source | AP00694apd / linked |
| CTPDB_P014813_ACT_apd_0002 | Antimicrobial | Antifungal | Not available in the current structured import | Unknown | Not reported by source | AP00694apd / linked |
| CTPDB_P014813_ACT_apd_0004 | Enzyme Inhibitor | General Enzyme Inhibitor | Not available in the current structured import | Unknown | Not reported by source | AP00694apd / linked |
| CTPDB_P014813_ACT_apd_0005 | Toxicity | Hemolytic | Not available in the current structured import | Unknown | Not reported by source | AP00694apd / linked |
| CTPDB_P014813_ACT_camp_0006 | Antimicrobial | Antibacterial | Not available in the current structured import | Unknown | Not reported by source | CAMPSQ156camp / linked |
| CTPDB_P014813_ACT_camp_0007 | Antimicrobial | Antifungal | Not available in the current structured import | Unknown | Not reported by source | CAMPSQ156camp / linked |
| CTPDB_P014813_ACT_camp_0008 | Anticancer | - | Not available in the current structured import | Unknown | Not reported by source | CAMPSQ156camp / linked |
| CTPDB_P014813_ACT_camp_0009 | Antimicrobial | Anti-Gram+ | Not available in the current structured import | Unknown | Not reported by source | CAMPSQ156camp / linked |
| CTPDB_P014813_ACT_camp_0010 | Antimicrobial | Anti-Gram- | Not available in the current structured import | Unknown | Not reported by source | CAMPSQ156camp / linked |
| CTPDB_P014813_ACT_cancerppd_0011 | Anticancer | Anticancer | Not available in the current structured import | Unknown | Not Available | 4433cancerppd / linked |
| CTPDB_P014813_ACT_dbaasp_0012 | Antimicrobial | - | 3.5 µM | Staphylococcus aureus NCTC 8325 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0013 | Antimicrobial | - | 20 µM | Escherichia coli ATCC 25922 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0014 | Antimicrobial | - | 19 µM | Candida albicans ATCC 90028 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0015 | Antimicrobial | - | NA | Human rhinovirus 2 (HRV2) | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0016 | Antimicrobial | - | 14 µM | Mouse T-lymphoma cells EL4 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0017 | Antimicrobial | - | 12.5 µM | Escherichia coli ATCC 25922 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0018 | Antimicrobial | - | 50 µM | Klebsiella pneumoniae KK3 9904 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0019 | Antimicrobial | - | 12.5 µM | Enterobacter cloacae HNTCC 53001 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0020 | Antimicrobial | - | 25 µM | Pseudomonas aeruginosa ATCC 27853 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0021 | Antimicrobial | - | 50 µM | Salmonella enterica subsp. enterica serovar Typhimurium LT2 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0022 | Antimicrobial | - | >100 µM | Proteus mirabilis ATCC 25933 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0023 | Antimicrobial | - | 6 µM | Staphylococcus aureus NCTC 8325 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0024 | Antimicrobial | - | 3 µM | Staphylococcus epidermidis RP62A | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0025 | Antimicrobial | - | 6 µM | Enterococcus faecalis ATCC 29212 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0026 | Antimicrobial | - | 12.5 µM | Streptococcus group B HNTCC 80130 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0027 | Antimicrobial | - | 12.5 µM | Candida albicans ATCC 90028 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0028 | Antimicrobial | - | 2.5 µM | Staphylococcus aureus T7/5 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0029 | Antimicrobial | - | 5 µM | Staphylococcus aureus T27/9 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0030 | Antimicrobial | - | 20 µM | Staphylococcus aureus T58/7 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0031 | Antimicrobial | - | >50 µM | Bacteroides fragilis ATCC 25285 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0032 | Antimicrobial | - | >50 µM | Bacteroides fragilis | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0033 | Antimicrobial | - | 3 µM | Prevotella melaninogenica | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0034 | Antimicrobial | - | 50 µM | Fusobacterium varium ATCC 27725 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0035 | Antimicrobial | - | >50 µM | Fusobacterium nucleatum | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0036 | Antimicrobial | - | 12.5 µM | Clostridium tertium ATCC 19465 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0037 | Antimicrobial | - | >50 µM | Clostridium perfringens ATCC 10543 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0038 | Antimicrobial | - | 12.5 µM | Clostridium septicum | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0039 | Antimicrobial | - | 12.5 µM | Cutibacterium acnes ATCC 11828 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0040 | Antimicrobial | - | 25 µM | Cutibacterium acnes | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0041 | Antimicrobial | - | 50 µM | Peptoniphilus asaccharolyticus ATCC 29743 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0042 | Antimicrobial | - | 25 µM | Peptostreptococcus anaerobius | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0043 | Antimicrobial | - | 25 µM | Escherichia coli CGMCC 1.8732 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0044 | Antimicrobial | - | 12.5 µM | Pseudomonas aeruginosa CGMCC 1.2421 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0045 | Antimicrobial | - | 12.5 µM | Klebsiella pneumoniae CGMCC 1.1736 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0046 | Antimicrobial | - | 6.25 µM | Staphylococcus aureus CGMCC 1.8721 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0047 | Antimicrobial | - | 3.13 µM | Staphylococcus epidermidis CGMCC 1.4260 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0048 | Antimicrobial | - | 3.13 µM | Bacillus subtilis CGMCC 1.3376 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0049 | Antimicrobial | - | 25 µM | Batrachochytrium dendrobatidis | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0050 | Antimicrobial | - | 12.5 µM | Acinetobacter baumannii | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0051 | Antimicrobial | - | 0.39 µM | HSV-1 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0052 | Antimicrobial | - | 3.125 µM | Mink enteritis virus (MeV) | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0053 | Antimicrobial | - | 3.125 µM | Human parainfluenza Virus 2 ( HPIV2) | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0054 | Antimicrobial | - | 3.125 µM | HCoV-229E | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0055 | Antimicrobial | - | 12.5 µM | SARS-CoV-2 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dbaasp_0056 | Antimicrobial | - | 3.12 µM | HSV-1 | Not reported by source | DBAASPS_2156_chain0dbaasp / linked |
| CTPDB_P014813_ACT_dramp_0057 | Antimicrobial | - | Not available in the current structured import | Unknown | Not reported by source | DRAMP01347dramp / linked |
| CTPDB_P014813_ACT_dramp_0058 | Antimicrobial | Antibacterial | Not available in the current structured import | Unknown | Not reported by source | DRAMP01347dramp / linked |
| CTPDB_P014813_ACT_dramp_0059 | Antimicrobial | Anti-Gram+ | Not available in the current structured import | Unknown | Not reported by source | DRAMP01347dramp / linked |
| CTPDB_P014813_ACT_dramp_0060 | Antimicrobial | Anti-Gram- | Not available in the current structured import | Unknown | Not reported by source | DRAMP01347dramp / linked |
| CTPDB_P014813_ACT_dramp_0061 | Antimicrobial | Antifungal | Not available in the current structured import | Unknown | Not reported by source | DRAMP01347dramp / linked |
| CTPDB_P014813_ACT_satpdb_0062 | Anticancer | - | Not available in the current structured import | Unknown | Not reported by source | satpdb11811satpdb / linked |
| CTPDB_P014813_ACT_satpdb_0063 | Antimicrobial | Antibacterial | Not available in the current structured import | Unknown | Not reported by source | satpdb11811satpdb / linked |
| CTPDB_P014813_ACT_satpdb_0064 | Antimicrobial | - | Not available in the current structured import | Unknown | Not reported by source | satpdb11811satpdb / linked |
| CTPDB_P014813_ACT_satpdb_0065 | Antimicrobial | Antifungal | Not available in the current structured import | Unknown | Not reported by source | satpdb11811satpdb / linked |
| CTPDB_P014813_ACT_satpdb_0066 | Antimicrobial | Antibacterial | Not available in the current structured import | Unknown | Not reported by source | satpdb14614satpdb / linked |
| CTPDB_P014813_ACT_satpdb_0067 | Toxicity | General Toxic | Not available in the current structured import | Unknown | Not reported by source | satpdb14614satpdb / linked |
| CTPDB_P014813_ACT_satpdb_0068 | Antimicrobial | - | Not available in the current structured import | Unknown | Not reported by source | satpdb14614satpdb / linked |
| CTPDB_P014813_ACT_satpdb_0069 | Antimicrobial | Antifungal | Not available in the current structured import | Unknown | Not reported by source | satpdb14614satpdb / linked |
Sequence-linked cross-layer evidence
31
Records
2
Papers
21
Positive
10
Negative
1
Primary identities
These observations were collected directly from primary literature and linked by identical normalized sequence. They remain a separate evidence layer and do not overwrite Integrated source-database annotations.
Provenance
AIGSILGALAKGLPTLISWIKNR
AIGSILGALAKGLPTLISWIKNR
AIGSILGALAKGLPTLISWIKNR
AIGSILGALAKGLPTLISWIKNR
AIGSILGALAKGLPTLISWIKNR
AIGSILGALAKGLPTLISWIKNR
AIGSILGALAKGLPTLISWIKNR
Citation trail
Conlon JM, Sonnevend A, Patel M, Camasamudram V, Nowotny N, Zilahi E, Iwamuro S, Nielsen PF, Pál T.2003
-
Conlon JM, Sonnevend A, Patel M, Camasamudram V, Nowotny N, Zilahi E, Iwamuro S, Nielsen PF, Pál T
Conlon JM, Sonnevend A, Patel M, Camasamudram V, Nowotny N, Zilahi E, Iwamuro S, Nielsen PF, Pál T
Conlon JM, Sonnevend A, Patel M, Camasamudram V, Nowotny N, Zilahi E, Iwamuro S, Nielsen PF, Pál T
Conlon JM, Sonnevend A, Patel M, Camasamudram V, Nowotny N, Zilahi E, Iwamuro S, Nielsen PF, Pál T##Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.##Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji
Audit surface
Integrated record last updated: 2026-04-15T00:59:12.203743+00:00
Modification summary
No structured modification annotations are available for this record.
{
"toxicity": [
{
"unit": "µM",
"value": "8",
"source_db": "dbaasp",
"assay_method": "50% Hemolysis",
"toxicity_type": "Hemolytic",
"target_cellline": "Human erythrocytes"
},
{
"unit": "µM",
"value": "20",
"source_db": "dbaasp",
"assay_method": "50% Cell death",
"toxicity_type": "Cytotoxic",
"target_cellline": "Mouse fibroblasts L929"
},
{
"unit": "µM",
"value": "3.13",
"source_db": "dbaasp",
"assay_method": "10% Hemolysis",
"toxicity_type": "Hemolytic",
"target_cellline": "Human erythrocytes"
},
{
"unit": "µM",
"source_db": "dramp",
"assay_method": "[Ref.27271216] 100% hemolysis at 20 μM against human red blood cells",
"toxicity_type": "Hemolytic",
"target_cellline": "Erythrocytes"
},
{
"unit": "µM",
"source_db": "dramp",
"assay_method": "[Ref.12804591]Display cytotoxic against L929 fibroblasts(LC50=20 μM);EL4 T-lymphoma cells(LC50=14 μM).##[Ref.27271216]L929 cells:Cell viability is approximately 10% at the concentration of 6.25 μM.",
"toxicity_type": "Cytotoxic"
}
]
}[
{
"source_db": "apd",
"organism_name": "Unknown"
},
{
"source_db": "camp",
"organism_name": "Unknown"
},
{
"source_db": "cancerppd",
"organism_name": "Unknown"
},
{
"source_db": "dbaasp",
"organism_name": "Unknown"
},
{
"source_db": "dramp",
"organism_name": "Unknown"
},
{
"source_db": "satpdb",
"organism_name": "Unknown"
}
]{
"pdb_id": "6dst resolved by NMR (related PDB_ID)",
"source_db": "dramp"
}